Correlation Between Pfizer and 23291KAJ4

Can any of the company-specific risk be diversified away by investing in both Pfizer and 23291KAJ4 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and 23291KAJ4 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and DH EUROPE FINANCE, you can compare the effects of market volatilities on Pfizer and 23291KAJ4 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of 23291KAJ4. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and 23291KAJ4.

Diversification Opportunities for Pfizer and 23291KAJ4

0.01

Correlation Coefficient

Pfizer  23291KAJ4

Significant diversification

The 3 months correlation between Pfizer and 23291KAJ4 is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and DH EUROPE FINANCE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DH EUROPE FINANCE and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with 23291KAJ4. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DH EUROPE FINANCE has no effect on the direction of Pfizer i.e., Pfizer and 23291KAJ4 go up and down completely randomly.

Pair Corralation between Pfizer and 23291KAJ4

Considering the 90-day investment horizon Pfizer is expected to generate 8.25 times less return on investment than 23291KAJ4. But when comparing it to its historical volatility, Pfizer Inc is 1.19 times less risky than 23291KAJ4. It trades about 0.01 of its potential returns per unit of risk. DH EUROPE FINANCE is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  7,762  in DH EUROPE FINANCE on December 26, 2024 and sell it today you would earn a total of  226.00  from holding DH EUROPE FINANCE or generate 2.91% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	96.67%
Values	Daily Returns

Pfizer Inc  vs.  DH EUROPE FINANCE

Pfizer Inc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

DH EUROPE FINANCE

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in DH EUROPE FINANCE are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, 23291KAJ4 is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Pfizer and 23291KAJ4

The main advantage of trading using opposite Pfizer and 23291KAJ4 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, 23291KAJ4 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 23291KAJ4 will offset losses from the drop in 23291KAJ4's long position.

The idea behind Pfizer Inc and DH EUROPE FINANCE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.